Epsilon M&A Deal Report - Sagitta Pharma (T&J Healthcare)
Transaction Multiples for the Valuation of Private Companies
Private group led by Isatis Capital, BNP Paribas Développement / Sagitta Pharma (T&J Healthcare)
No EMAT :
107980
Announced Date :
25/02/2021
Type :
MBO (Management Buy Out)
Deal Value :
Yes
Acquirer :
Private group led by Isatis Capital, BNP Paribas Développement
Target :
Sagitta Pharma (T&J Healthcare)
Country :
Indre-Et-Loire
Sector of activity :
- Pharmaceuticals & Cosmetics R&W > Retail and Wholesale ('R&W') > Drugs Retailers
Business Description :
Founded in 2009, Sagitta Pharma is a distribution group for health products (reimbursed medicines, OTC medicines, parapharmaceutical products, food supplements, veterinary medicines) acting as a...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Drugs Retailers » = 51
| Date | Acquirer | Target | Country | Multiples | See details |
| 04/10/2019 | Series A funding round led by Capital Croissance | Onatera (Maboutiqueonaturel) | France | * | 107706 |
| 02/09/2021 | BHG Group | AH-Trading | Germany | *** | 107281 |
Source: Epsilon Research / EMAT
